{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:47:51Z","timestamp":1791337671998,"version":"4.3.1"},"reference-count":98,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2021.10443","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T09:47:04Z","timestamp":1626342424000},"source":"Crossref","is-referenced-by-count":9,"title":["Current advances in metabolomic studies on non\u2011motor psychiatric manifestations of Parkinson's disease (Review)"],"prefix":"10.3892","volume":"22","author":[{"given":"Adela","family":"Ciobanu","sequence":"first","affiliation":[{"name":"Department of Psychiatry, \u2018Prof. Dr. Alexandru Obregia\u2019 Clinical Psychiatric Hospital, 041914 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Ionita","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, \u2018Prof. Dr. Alexandru Obregia\u2019 Clinical Psychiatric Hospital, 041914 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Buleandra","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry, Faculty of Chemistry, University of Bucharest, 050663 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iulia","family":"David","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry, Faculty of Chemistry, University of Bucharest, 050663 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Popa","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry, Faculty of Chemistry, University of Bucharest, 050663 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Ciucu","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry, Faculty of Chemistry, University of Bucharest, 050663 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Budisteanu","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Genetics, \u2018Victor Babes\u2019 National Institute of Pathology, 050096 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"key20210812133100_b1-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson's disease","volume":"56","author":"Gelb","year":"1999","journal-title":"Arch Neurol"},{"issue":"42","key":"key20210812133100_b2-etm-0-0-10443","doi-asserted-by":"publisher","DOI":"10.3390\/metabo7030042","article-title":"Biomarker research in Parkinson's disease using metabolite profiling","volume":"7","author":"Havelund","year":"2017","journal-title":"Metabolites"},{"issue":"111","key":"key20210812133100_b3-etm-0-0-10443","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2019.00111","article-title":"Fast intracortical sensory-motor integration: A window into the pathophysiology of Parkinson's disease","volume":"13","author":"Dubbioso","year":"2019","journal-title":"Front Hum Neurosci"},{"issue":"612","key":"key20210812133100_b4-etm-0-0-10443","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00612","article-title":"Parkinson's disease: Biomarkers, treatment, and risk factors","volume":"12","author":"Emamzadeh","year":"2018","journal-title":"Front Neurosci"},{"key":"key20210812133100_b5-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Aging and Parkinson's disease: Substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"key20210812133100_b6-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: Diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol"},{"key":"key20210812133100_b7-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1468-1331.2009.02900.x","article-title":"Neurotransmission in Parkinson's disease: Beyond dopamine","volume":"17","author":"Barone","year":"2010","journal-title":"Eur J Neurol"},{"key":"key20210812133100_b8-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10072-018-3585-x","article-title":"Understanding multifactorial architecture of Parkinson's disease: Pathophysiology to management","volume":"40","author":"Kaur","year":"2019","journal-title":"Neurol Sci"},{"key":"key20210812133100_b9-etm-0-0-10443","doi-asserted-by":"crossref","first-page":"140","DOI":"10.31925\/farmacia.2019.1.19","article-title":"The usefulness of dexamethasone in the treatment of chronic subdural hematomas","volume":"67","author":"Papacocea","year":"2019","journal-title":"Farmacia"},{"issue":"156","key":"key20210812133100_b10-etm-0-0-10443","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00156","article-title":"Diagnostic criteria for Parkinson's disease: From James Parkinson to the concept of prodromal disease","volume":"9","author":"Marsili","year":"2018","journal-title":"Front Neurol"},{"key":"key20210812133100_b11-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/NRL.0b013e318183fdd8","article-title":"Molecular imaging studies in Parkinson's disease: Reducing diagnostic uncertainty","volume":"15","author":"Felicio","year":"2009","journal-title":"Neurologist"},{"key":"key20210812133100_b12-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1212\/WNL.0000000000002350","article-title":"Accuracy of clinical diagnosis of Parkinson's disease: A systematic review and meta-analysis","volume":"86","author":"Rizzo","year":"2016","journal-title":"Neurology"},{"issue":"3","key":"key20210812133100_b13-etm-0-0-10443","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0304-2","article-title":"Recent advances and perspectives of metabolomics-based investigations in Parkinson's disease","volume":"14","author":"Shao","year":"2019","journal-title":"Mol Neurodegener"},{"key":"key20210812133100_b14-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1600-0404.1994.tb01674.x","article-title":"Clinical diagnosis of Parkinson's disease. Proposal of diagnostic subgroups classified at different levels of confidence","volume":"89","author":"Larsen","year":"1994","journal-title":"Acta Neurol Scand"},{"key":"key20210812133100_b15-etm-0-0-10443","first-page":"1118","article-title":"Antioxidant enzymes-potential targets in intracerebral haemorrhage","volume":"62","author":"Papacocea","year":"2014","journal-title":"Farmacia"},{"key":"key20210812133100_b16-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1093\/brain\/aws055","article-title":"Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies","volume":"135","author":"Goldstein","year":"2012","journal-title":"Brain"},{"key":"key20210812133100_b17-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/BF01276419","article-title":"Elevated 5-S-cysteinyldopamine\/homovanillic acid ratio and reduced homovanillic acid in cerebrospinal fluid: Possible markers for and potential insights into the pathoetiology of Parkinson's disease","volume":"103","author":"Cheng","year":"1996","journal-title":"J Neural Transm (Vienna)"},{"key":"key20210812133100_b18-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","article-title":"CSF and blood biomarkers for Parkinson's disease","volume":"18","author":"Parnetti","year":"2019","journal-title":"Lancet Neurol"},{"key":"key20210812133100_b19-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/mds.27110","article-title":"Diagnostic utility of cerebrospinal fluid \u03b1-synuclein in Parkinson's disease: A systematic review and meta-analysis","volume":"32","author":"Eusebi","year":"2017","journal-title":"Mov Disord"},{"key":"key20210812133100_b20-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3109\/00207454.2014.961454","article-title":"Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson's disease diagnosis: A systematic review and meta-analysis","volume":"125","author":"Gao","year":"2015","journal-title":"Int J Neurosci"},{"issue":"7","key":"key20210812133100_b21-etm-0-0-10443","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-016-0072-9","article-title":"Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease","volume":"11","author":"Majbour","year":"2016","journal-title":"Mol Neurodegener"},{"key":"key20210812133100_b22-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/mds.25772","article-title":"Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease","volume":"29","author":"Parnetti","year":"2014","journal-title":"Mov Disord"},{"key":"key20210812133100_b23-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1212\/WNL.0000000000004609","article-title":"Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls","volume":"19","author":"Mollenhauer","year":"2017","journal-title":"Neurology"},{"key":"key20210812133100_b24-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1212\/WNL.0000000000002651","article-title":"Monitoring of 30 marker candidates in early Parkinson disease as progression markers","volume":"2","author":"Mollenhauer","year":"2016","journal-title":"Neurology"},{"key":"key20210812133100_b25-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.aca.2019.09.013","article-title":"Electrochemical biosensors for the detection and study of \u03b1-synuclein related to Parkinson's disease- A review","volume":"1089","author":"Hassan","year":"2019","journal-title":"Anal Chim Acta"},{"key":"key20210812133100_b26-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1136\/jnnp-2014-309562","article-title":"A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes","volume":"86","author":"Magdalinou","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20210812133100_b27-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","article-title":"Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder","volume":"88","author":"Hansson","year":"2017","journal-title":"Neurology"},{"key":"key20210812133100_b28-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/archneurol.2009.247","article-title":"Urate as a predictor of the rate of clinical decline in Parkinson's disease","volume":"66","author":"Ascherio","year":"2009","journal-title":"Arch Neurol"},{"key":"key20210812133100_b29-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/BF02261005","article-title":"The urate and xanthine concentrations in the cerebrospinal fluid in patients with vascular dementia of the Binswanger type, Alzheimer type dementia, and Parkinson's disease","volume":"6","author":"Tohgi","year":"1993","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"key20210812133100_b30-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.brainres.2011.06.057","article-title":"CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's disease","volume":"1408","author":"LeWitt","year":"2011","journal-title":"Brain Res"},{"key":"key20210812133100_b31-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.clinbiochem.2009.03.020","article-title":"Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients","volume":"42","author":"Amorini","year":"2009","journal-title":"Clin Biochem"},{"key":"key20210812133100_b32-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s0304-3940(97)00840-9","article-title":"Cerebrospinal fluid hypoxanthine, xanthine and uric acid levels may reflect glutamate-mediated excitotoxicity in different neurological diseases","volume":"28","author":"Stover","year":"1997","journal-title":"Neurosci Lett"},{"key":"key20210812133100_b33-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/jamaneurol.2013.5528","article-title":"Inosine to increase serum and cerebrospinal fluid urate in Parkinson's disease: A randomized clinical trial","volume":"71","author":"Schwarzschild","year":"2014","journal-title":"JAMA Neurol"},{"issue":"e003620","key":"key20210812133100_b34-etm-0-0-10443","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003620","article-title":"Low uric acid levels in patients with Parkinson's disease: Evidence from meta-analysis","volume":"3","author":"Shen","year":"2013","journal-title":"BMJ Open"},{"key":"key20210812133100_b35-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2217\/bmm.10.94","article-title":"Urate: A novel biomarker of Parkinson's disease risk, diagnosis and prognosis","volume":"4","author":"Cipriani","year":"2010","journal-title":"Biomark Med"},{"key":"key20210812133100_b36-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1001\/archneur.2008.65.6.nct70003","article-title":"Serum urate as a predictor of clinical and radiographic progression in Parkinson's disease","volume":"65","author":"Schwarzschild","year":"2008","journal-title":"Arch Neurol"},{"key":"key20210812133100_b37-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3164\/jcbn.13-108","article-title":"Oxidized DJ-1 as a possible biomarker of Parkinson's disease","volume":"54","author":"Saito","year":"2014","journal-title":"J Clin Biochem Nutr"},{"issue":"107734","key":"key20210812133100_b38-etm-0-0-10443","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioelechem.2020.107734","article-title":"A nano-composite based regenerative neuro biosensor sensitive to Parkinsonism-associated protein DJ-1\/Park7 in cerebrospinal fluid and saliva","volume":"138","author":"Sonu\u00e7 Karabo\u011fa","year":"2021","journal-title":"Bioelectrochem"},{"issue":"112016","key":"key20210812133100_b39-etm-0-0-10443","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2020.112016","article-title":"Flexible platinum electrodes as electrochemical sensor and immunosensor for Parkinson's disease biomarkers","volume":"152","author":"Carvalho","year":"2020","journal-title":"Biosens Bioelectron"},{"key":"key20210812133100_b40-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000112832","article-title":"Red blood cells are the major source of alpha-synuclein in blood","volume":"5","author":"Barbour","year":"2008","journal-title":"Neurodegener Dis"},{"key":"key20210812133100_b41-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ejn.13056","article-title":"Oligomeric \u03b1-synuclein and \u03b2-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases","volume":"43","author":"Williams","year":"2016","journal-title":"Eur J Neurosci"},{"issue":"53","key":"key20210812133100_b42-etm-0-0-10443","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00053","article-title":"\u03b1-Synuclein heterocomplexes with \u03b2-amyloid are increased in red blood cells of Parkinson's disease patients and correlate with disease severity","volume":"11","author":"Daniele","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"key20210812133100_b43-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/jnc.14104","article-title":"Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia","volume":"142","author":"Havelund","year":"2017","journal-title":"J Neurochem"},{"key":"key20210812133100_b44-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.1007\/s12035-017-0845-3","article-title":"Alternations of metabolic profile and kynurenine metabolism in the plasma of Parkinson's disease","volume":"55","author":"Chang","year":"2018","journal-title":"Mol Neurobiol"},{"issue":"50","key":"key20210812133100_b45-etm-0-0-10443","doi-asserted-by":"publisher","DOI":"10.3390\/metabo8030050","article-title":"Potential metabolomic linkage in blood between Parkinson's disease and traumatic brain injury","volume":"8","author":"Fiandaca","year":"2018","journal-title":"Metabolites"},{"key":"key20210812133100_b46-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"S175","DOI":"10.1002\/ana.410440726","article-title":"Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: A target for neuroprotection","volume":"44 (3 Suppl 1)","author":"Rodriguez","year":"1998","journal-title":"Ann Neurol"},{"key":"key20210812133100_b47-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cca.2018.02.022","article-title":"Serum metabolomics study in a group of Parkinson's disease patients from northern India","volume":"480","author":"Nagesh Babu","year":"2018","journal-title":"Clin Chim Acta"},{"issue":"226","key":"key20210812133100_b48-etm-0-0-10443","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2018.00226","article-title":"Metabolomic profiles for primary progressive multiple sclerosis stratification and disease course monitoring","volume":"12","author":"Stoessel","year":"2018","journal-title":"Front Hum Neurosci"},{"key":"key20210812133100_b49-etm-0-0-10443","first-page":"99","article-title":"Cystic meningioma","volume":"104","author":"Papacocea","year":"2009","journal-title":"Chirurgia (Bucur)"},{"key":"key20210812133100_b50-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.parkreldis.2010.11.004","article-title":"Urinary8-hydroxydeoxyguanosine correlate with hallucinations rather than motor symptoms in Parkinson's disease","volume":"17","author":"Hirayama","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"key20210812133100_b51-etm-0-0-10443","first-page":"859","article-title":"Plasma and urinary HPLC-ED determination of the ratio of 8-OHdG\/2-dG in Parkinson's disease","volume":"57","author":"Bolner","year":"2011","journal-title":"Clin Lab"},{"key":"key20210812133100_b52-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1212\/01.WNL.0000154597.24838.6B","article-title":"Urinary 8-hydroxydeoxy-guanosine levels as a biomarker for progression of Parkinson disease","volume":"64","author":"Sato","year":"2005","journal-title":"Neurology"},{"key":"key20210812133100_b53-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.parkreldis.2015.09.009","article-title":"Elevated excretion of biopyrrin as a new marker for idiopathic Parkinson's disease","volume":"21","author":"Luan","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"key20210812133100_b54-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.3748\/wjg.v21.i37.10609","article-title":"Brain-gut-microbiota axis in Parkinson's disease","volume":"21","author":"Mulak","year":"2015","journal-title":"World J Gastroenterol"},{"key":"key20210812133100_b55-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41588-018-0135-7","article-title":"The fecal metabolome as a functional readout of the gut microbiome","volume":"50","author":"Zierer","year":"2018","journal-title":"Nat Genet"},{"key":"key20210812133100_b56-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","article-title":"Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls","volume":"32","author":"Unger","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"key20210812133100_b57-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S1474-4422(13)70054-1","article-title":"Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease","volume":"12","author":"Boeve","year":"2013","journal-title":"Lancet Neurol"},{"key":"key20210812133100_b58-etm-0-0-10443","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.37358\/RC.19.4.7146","article-title":"The effects of caffeine intake on cardiovascular parameters in sleep deprived medical residents","volume":"70","author":"Papacocea","year":"2019","journal-title":"Rev Chim"},{"key":"key20210812133100_b59-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/mds.10010","article-title":"Factors impacting on quality of life in Parkinson's disease: Results from an international survey","volume":"17","year":"2002","journal-title":"Mov Disord"},{"key":"key20210812133100_b60-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1136\/jnnp.69.3.308","article-title":"What contributes to quality of life in patients with Parkinson's disease?","volume":"69","author":"Schrag","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20210812133100_b61-etm-0-0-10443","first-page":"S1203","article-title":"Frontal epidural empyema (Pott's puffy tumor) associated with Mycoplasma and depression","volume":"55 (Suppl 3)","author":"Ciobanu","year":"2014","journal-title":"Rom J Morphol Embryol"},{"key":"key20210812133100_b62-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1212\/WNL.0000000000002898","article-title":"Detecting depression in Parkinson's disease: A systematic review and meta-analysis","volume":"87","author":"Goodarzi","year":"2016","journal-title":"Neurology"},{"key":"key20210812133100_b63-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson's disease: Loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"key":"key20210812133100_b64-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.parkreldis.2015.05.016","article-title":"Reduced plasma serotonin and 5-hydroxyindoleacetic acid levels in Parkinson's disease are associated with nonmotor symptoms","volume":"21","author":"Tong","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"key20210812133100_b65-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnmol.2018.00257","article-title":"Integrated analysis reveals altered lipid and glucose metabolism and identifies NOTCH2 as a biomarker for Parkinson's disease related depression","volume":"31","author":"Dong","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"key20210812133100_b66-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"928","DOI":"10.2337\/dc12-0239","article-title":"Glycemia, insulin resistance, insulin secretion, and risk of depressive symptoms in middle age","volume":"36","author":"Akbaraly","year":"2013","journal-title":"Diabetes Care"},{"key":"key20210812133100_b67-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jad.2017.02.002","article-title":"Serum lipid levels in depression and suicidality: The Korea National Health and Nutrition Examination Survey (KNHANES) 2014","volume":"213","author":"Oh","year":"2017","journal-title":"J Affect Disord"},{"key":"key20210812133100_b68-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/mds.26032","article-title":"Dietary fat intake and risk for Parkinson's disease","volume":"29","author":"Dong","year":"2014","journal-title":"Mov Disord"},{"key":"key20210812133100_b69-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s12035-014-8718-5","article-title":"Linoleic acid derivative DCP-LA ameliorates stress-induced depression-related behavior by promoting cell surface 5-HT1A receptor translocation, stimulating serotonin release, and inactivating GSK-3\u03b2","volume":"51","author":"Kanno","year":"2015","journal-title":"Mol Neurobiol"},{"key":"key20210812133100_b70-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1017\/s0033291700022261","article-title":"Left-sided Parkinson's disease is associated with greater anxiety and depression","volume":"21","author":"Fleminger","year":"1991","journal-title":"Psychol Med"},{"key":"key20210812133100_b71-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1176\/appi.ajp.162.4.814-a","article-title":"Pramipexole, ropinirole, and mania in Parkinson's disease","volume":"162","author":"Singh","year":"2005","journal-title":"Am J Psychiatry"},{"key":"key20210812133100_b72-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/mds.20325","article-title":"Movement disorder emergencies","volume":"20","author":"Kipps","year":"2005","journal-title":"Mov Disord"},{"key":"key20210812133100_b73-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/j.1532-5415.2000.tb06891.x","article-title":"Predictors of nursing home placement in Parkinson's disease: A population-based, prospective study","volume":"48","author":"Aarsland","year":"2000","journal-title":"J Am Geriatr Soc"},{"key":"key20210812133100_b74-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/mds.20308","article-title":"Repeated visual hallucinations in Parkinson's disease as disturbed external\/internal perceptions: Focused review and a new integrative model","volume":"20","author":"Diederich","year":"2005","journal-title":"Mov Disord"},{"key":"key20210812133100_b75-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/brain\/123.4.733","article-title":"Hallucinations in Parkinson's disease: Prevalence, phenomenology, and risk factors","volume":"123","author":"F\u00e9nelon","year":"2000","journal-title":"Brain"},{"key":"key20210812133100_b76-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1017\/S0033291718003161","article-title":"Auditory and visual hallucination prevalence in Parkinson's disease and dementia with Lewy bodies: A systematic review and meta-analysis","volume":"49","author":"Eversfield","year":"2019","journal-title":"Psychol Med"},{"key":"key20210812133100_b77-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/s1474-4422(03)00351-x","article-title":"Dementia associated with Parkinson's disease","volume":"2","author":"Emre","year":"2003","journal-title":"Lancet Neurol"},{"key":"key20210812133100_b78-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1212\/wnl.46.3.678","article-title":"Hippocampal volumes in Alzheimer's disease, Parkinson's disease with or without dementia: An MRI study","volume":"46","author":"Laakso","year":"1996","journal-title":"Neurology"},{"key":"key20210812133100_b79-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"S748","DOI":"10.1002\/mds.22670","article-title":"MRI and cognitive impairment in Parkinson's disease","volume":"24 (Suppl 2)","author":"Ibarretxe-Bilbao","year":"2009","journal-title":"Mov Disord"},{"key":"key20210812133100_b80-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.neurobiolaging.2007.02.002","article-title":"Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease","volume":"29","author":"Bouchard","year":"2008","journal-title":"Neurobiol Aging"},{"key":"key20210812133100_b81-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000153432","article-title":"A volumetric magnetic resonance imaging study of entorhinal cortex volume in dementia with Lewy bodies. A comparison with Alzheimer's disease and Parkinson's disease with and without dementia","volume":"26","author":"Kenny","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"key":"key20210812133100_b82-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/mds.20652","article-title":"Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging","volume":"20","author":"Burton","year":"2005","journal-title":"Mov Disord"},{"key":"key20210812133100_b83-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1001\/archneur.60.12.1745","article-title":"Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: An in vivo positron emission tomographic study","volume":"60","author":"Bohnen","year":"2003","journal-title":"Arch Neurol"},{"key":"key20210812133100_b84-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/s0149-7634(96)00043-7","article-title":"Dopamine\/glutamate interactions in Parkinson's disease","volume":"21","author":"Lange","year":"1997","journal-title":"Neurosci Biobehav Rev"},{"key":"key20210812133100_b85-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/pl00007756","article-title":"Involvement of non-dopaminergic pathways in Parkinson's disease: Pathophysiology and therapeutic implications","volume":"13","author":"Bonnet","year":"2000","journal-title":"CNS Drugs"},{"key":"key20210812133100_b86-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.2147\/NDT.S219288","article-title":"Affective theory of mind in Parkinson's disease: The effect of cognitive performance","volume":"15","author":"Romosan","year":"2019","journal-title":"Neuropsychiatr Dis Treat"},{"key":"key20210812133100_b87-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1212\/WNL.0000000000000425","article-title":"CSF A\u03b242 predicts early-onset dementia in Parkinson's disease","volume":"82","author":"Alves","year":"2014","journal-title":"Neurology"},{"key":"key20210812133100_b88-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/archneurol.2012.1654","article-title":"Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and\/or parkinsonian disorders","volume":"69","author":"Hall","year":"2012","journal-title":"Arch Neurol"},{"key":"key20210812133100_b89-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/gps.2496","article-title":"The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia","volume":"26","author":"Andersson","year":"2011","journal-title":"Int J Geriatr Psychiatry"},{"issue":"114545","key":"key20210812133100_b90-etm-0-0-10443","article-title":"Immunoaffinity biosensor for neurofilament light chain detection and its use in Parkinson's diagnosis","volume":"256","author":"\u00d6zg\u00fcr","year":"2020","journal-title":"Mater Sci Eng B"},{"key":"key20210812133100_b91-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s00415-009-5357-2","article-title":"Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson's disease","volume":"257","author":"Scalzo","year":"2010","journal-title":"J Neurol"},{"issue":"e0150552","key":"key20210812133100_b92-etm-0-0-10443","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150552","article-title":"Insulin-like growth factor 1 (IGF-1) in Parkinson's disease: Potential as trait-, progression- and prediction marker and confounding factors","volume":"11","author":"Bernhard","year":"2016","journal-title":"PLoS One"},{"issue":"107532","key":"key20210812133100_b93-etm-0-0-10443","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioelechem.2020.107532","article-title":"Validation of an in vivo electrochemical immunosensing platform for simultaneous detection of multiple cytokines in Parkinson's disease mice model","volume":"134","author":"Shen","year":"2020","journal-title":"Bioelectrochem"},{"issue":"952375","key":"key20210812133100_b94-etm-0-0-10443","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/952375","article-title":"Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease","volume":"2013","author":"More","year":"2013","journal-title":"Mediators Inflamm"},{"key":"key20210812133100_b95-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1471-2377-14-113","article-title":"Potential biomarkers relating pathological proteins, neuroinflammatory factors and free radicals in PD patients with cognitive impairment: A cross-sectional study","volume":"14","author":"Yu","year":"2014","journal-title":"BMC Neurol"},{"key":"key20210812133100_b96-etm-0-0-10443","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"key20210812133100_b97-etm-0-0-10443","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/1573411012666160601161703","article-title":"Voltammetric method for simultaneous determination of L-Dopa and benserazide","volume":"13","author":"Rabinca","year":"2017","journal-title":"Curr Anal Chem"},{"key":"key20210812133100_b98-etm-0-0-10443","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1080\/00032710903521900","article-title":"Selective DPV method of dopamine determination in biological samples containing ascorbic acid","volume":"43","author":"Patrascu","year":"2010","journal-title":"Anal Lett"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T10:43:43Z","timestamp":1628765023000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2021.10443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":98,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,7,15]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2021.10443","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,15]]},"article-number":"1010"}}